RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
about
Periodontitis and bone metabolismThe role of osteoimmunology in periodontal diseaseHost modulation therapy: An indispensable part of perioceuticsβ-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal DiseaseThe enduring importance of animal models in understanding periodontal diseaseFAM5C contributes to aggressive periodontitis.Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats.Infection of RANKL-primed RAW-D macrophages with Porphyromonas gingivalis promotes osteoclastogenesis in a TNF-α-independent manner.Irradiation by light-emitting diode light as an adjunct to facilitate healing of experimental periodontitis in vivo.Review of osteoimmunology and the host response in endodontic and periodontal lesions.Inflammation and uncoupling as mechanisms of periodontal bone lossMechanisms of Bone Resorption in Periodontitis.RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.Pre-clinical models for oral and periodontal reconstructive therapies.Langerhans cells down-regulate inflammation-driven alveolar bone loss.In vitro evaluation of osteoprotegerin in chitosan for potential bone defect applications.Biochemical markers as predictors of bone remodelling in dental disorders: a narrative description of literaturePeriostin is down-regulated during periodontal inflammation.OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions.Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?Toll gates to periodontal host modulation and vaccine therapyHigh- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice.RANKL inhibition for the management of patients with benign metabolic bone disorders.Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta.What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?The RANKL-OPG system in clinical periodontology.Advanced reconstructive technologies for periodontal tissue repair.Periodontal disease: a genetic perspective.Rheumatoid arthritis in the elderly and its relationship with periodontitis: a review.Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability.Personalized medicine: an update of salivary biomarkers for periodontal diseases.Efficacy of stem cells on periodontal regeneration: Systematic review of pre-clinical studies.The osteoimmunology of alveolar bone loss.The emerging roles of B cells as partners and targets in periodontitis.Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages.In vivo osteoprotegerin gene therapy preventing bone loss induced by periodontitis.Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant.Inflammatory osteolysis: a conspiracy against bone.Murine Experimental Root Canal Infection: Cytokine Expression in Response to F. nucleatum and E. faecalis.
P2860
Q26775740-318A7B6F-8F68-4BB4-8AE4-015406582A31Q26822821-BEEB6251-DB54-4941-B0D7-449DF90F671CQ26852306-B8782EBF-102D-4193-AD82-225E031BC915Q27301038-8566B7D4-0C31-402F-A5ED-B5445E7FD208Q28085417-3987757D-23B7-4A06-A229-DA74839678D5Q33552325-C1E23BC0-83E1-4AC8-B5A4-9A9C00E13EE3Q34076658-E2B3AF84-6AC3-4339-BEFF-DD12ED8F638EQ34313876-834A8196-5E9C-47A9-BF45-719588CDDD70Q34356487-1EEDA60F-4069-40F4-95FC-544DCB7251CBQ34920792-ADB326A7-114A-436B-A8D9-7D77BD904837Q35129179-E287914F-0AB6-4A5B-AC25-237F2C7E16F5Q35612679-24070BD4-5EC8-4CB4-B38D-4D8E7C00AB75Q35766784-217A5654-CA18-461A-A30F-59309A756FEEQ35866617-C7E8C38B-91B6-400A-AABC-3107AC61A7B0Q35935681-5412B8D1-A9ED-4738-B931-B17BE9C6070AQ36135381-E81936C9-9868-4782-BDF6-800576DA888EQ36333489-5369C6F8-4589-4FA4-BA2B-516C531F5E48Q36474881-97E36990-7803-4E9B-81DB-AFCA5F8BF80EQ37199204-CAA9F7EE-61B6-4194-BF74-088CF7AE0D5DQ37286024-7050318A-2855-473F-92E2-2DB905B2DC27Q37358225-29D47F0D-B974-4280-8B31-978E6FE56B8DQ37416211-7C913470-7C83-4754-9494-5787BED77C65Q37463716-7DF9E0CC-CA71-49DB-804C-63140C2F9F28Q37532561-2AD7F41A-6649-4E4D-9F72-197B9770902FQ37579579-8428553F-2E9A-4ED8-9EB6-3B6F6698EC09Q37842638-4904530C-C5E1-4E07-9C85-CC2442B2B5EAQ37957292-4567FCFF-7ADD-447A-8D20-2496235A43FBQ38002946-80B4BC25-7972-4A59-BABA-DE71A41EC979Q38074059-615A9A45-BA06-4E4A-92BA-47745738FD63Q38093215-8DEDE54F-FDA1-4C55-B64F-9ABDDCFB3836Q38425187-62173DA5-41E0-4E92-A4A8-988CD4765E93Q38667950-B2BEDEFA-6A33-4D37-9DFE-5E356B5D5CB4Q38732579-1E7B3C32-751F-40AA-9DED-7F3221134A66Q38763612-557608EB-9CC2-4330-9E09-E05167BD3992Q38778320-4954A844-05BB-46D8-88C3-721D8B721C30Q38858001-EB704DDB-5F30-4D3D-9FBD-2FD88AF15BC4Q38958157-A6FE9508-ED95-4625-8351-7EE5034F236FQ39029251-57A2EBDC-55AA-4444-B2ED-659055D03C88Q39343563-87E130D4-A167-47E6-AB9D-F3948E891CDEQ40407412-C4BF9746-16C4-440F-A406-08495ED5A0B6
P2860
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
@en
type
label
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
@en
prefLabel
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
@en
P2093
P2860
P50
P356
P1476
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis
@en
P2093
Chan Ho Park
James V Sugai
Paul J Kostenuik
Qiming Jin
P2860
P304
P356
10.1902/JOP.2007.070073
P407
P577
2007-07-01T00:00:00Z